[1]
Rymbai, M. and Borah, V.V. 2026. Impact of the revised CLSI M100 (36th edition, 2026) minimum inhibitory concentration breakpoints on antimicrobial susceptibility interpretation and multidrug-resistance classification of clinical Pseudomonas aeruginosa isolates: a retrospective study. International Journal of Basic & Clinical Pharmacology. 15, 5 (Aug. 2026), 1002–1009. DOI:https://doi.org/10.18203/2319-2003.ijbcp20262873.